Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-12

Clinical Trial Update: Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update notes that a Phase 1/2 study of arginine hydrochloride for managing diabetic ketoacidosis in type 2 diabetes is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Arginine hydrochloride (Arginine hydrochloride)

Snippet

Sponsor: David K Carroll | Conditions: Diabetes (DM), Diabetic Ketoacidosis | Phase 1, Phase 2 | Status: RECRUITING